Literature DB >> 19036912

Estimating the prevalence of ex-injecting drug use in the population.

Mj Sweeting1, D De Angelis, Ae Ades, M Hickman.   

Abstract

Injecting drug use is the main route of transmission for the hepatitis C virus in the developed world. Knowledge about the characteristics of the past and current injecting drug user (IDU) population is therefore vital in order to understand the epidemiology of hepatitis C. The IDU population is ;hard to reach' and hence most epidemiological studies have concentrated on estimating current IDU prevalence, whilst little is known about the potentially large pool of ex-injectors. We demonstrate a method for estimating the proportion of ex-users in the population, by considering injecting drug use as a time-to-event process. We show how unbiased estimates of injecting duration and historical patterns in injecting initiation can be derived from a sample of ex-IDUs obtained from a population survey, and how such data lead to estimates of the proportion of ex-IDUs in the population. Finally, we show how to obtain estimates of the prevalence of ex-IDUs by using additional information on the prevalence of current IDUs.

Entities:  

Mesh:

Year:  2008        PMID: 19036912     DOI: 10.1177/0962280208094704

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  29 in total

1.  Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.

Authors:  Bálint Tresó; Erzsébet Barcsay; Anna Tarján; Gergely Horváth; Agnes Dencs; Andrea Hettmann; Mária Magdolna Csépai; Zoltán Gyori; Erzsébet Rusvai; Mária Takács
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

Review 2.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

3.  Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.

Authors:  Elizabeth Hancock; Zoe Ward; Rachel Ayres; Jane Neale; Deborah Hussey; Joanna May Kesten; Matthew Hickman; Peter Vickerman
Journal:  Addiction       Date:  2019-11-19       Impact factor: 6.526

4.  The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls.

Authors:  John Macleod; Lorraine Copeland; Matthew Hickman; James McKenzie; Jo Kimber; Daniela De Angelis; James R Robertson
Journal:  BMC Public Health       Date:  2010-02-26       Impact factor: 3.295

5.  Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

Authors:  Jo Kimber; Lorraine Copeland; Matthew Hickman; John Macleod; James McKenzie; Daniela De Angelis; James Roy Robertson
Journal:  BMJ       Date:  2010-07-01

Review 6.  Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.

Authors:  Reda M Chalhoub; Peter W Kalivas
Journal:  Drugs       Date:  2020-10       Impact factor: 9.546

7.  Global patterns of opioid use and dependence: harms to populations, interventions, and future action.

Authors:  Louisa Degenhardt; Jason Grebely; Jack Stone; Matthew Hickman; Peter Vickerman; Brandon D L Marshall; Julie Bruneau; Frederick L Altice; Graeme Henderson; Afarin Rahimi-Movaghar; Sarah Larney
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

8.  Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.

Authors:  Natasha K Martin; Matthew Hickman; Sharon J Hutchinson; David J Goldberg; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 9.  Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence.

Authors:  Matthew Hickman; Daniela De Angelis; Peter Vickerman; Sharon Hutchinson; Natasha Kaleta Martin
Journal:  Curr Opin Infect Dis       Date:  2015-12       Impact factor: 4.915

10.  Hepatitis C prevalence in Denmark -an estimate based on multiple national registers.

Authors:  Peer Brehm Christensen; Gordon Hay; Peter Jepsen; Lars Haukali Omland; Søren Andreas Just; Henrik Bygum Krarup; Nina Weis; Niels Obel; Susan Cowan
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.